Exposing Big Pharma’s Greed

Big Pharma has been playing a costly game, manipulating the patent system to keep drug prices sky-high—even on medications developed with taxpayer funding.

At Accountable.US, we’ve uncovered how drug manufacturers use tactics like pay-to-delay, evergreening, patent thickets, and product hopping to block generic competition and maintain their grip on the market. These strategies have allowed companies to rake in billions while Medicare and U.S. taxpayers foot the bill—leaving many patients, especially in lower-income and marginalized communities, struggling to afford the medications they need.

Explore our in-depth research, press releases, and latest news as we expose Big Pharma’s abuses and advocate for accountability in drug pricing. Learn how we’re fighting back against these unfair practices to ensure affordable access to life-saving medications for all Americans.

In The News

• Salon: Big Pharma “unleashed an army” of lawyers to avoid lowering Medicare drug costs: report
• Yahoo! Finance: Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions.
• Common Dreams: ‘New Era of Affordability’: Historic Medicare Negotiations Slash Drug Prices
• The Hill: Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last year: Report
• Rolling Stone: How Big Pharma is Fueling a Radical MAGA Agenda
• The Guardian: US Pharma group opposing abortion pill restrictions also backs Republicans attacking drug

Additional Research

• Conservative Groups Push to Overturn Inflation Reduction Act After $1M in PhRMA Contributions
• Fifth Circuit Pharma Conflicts
• PhRMA Gave Nearly $30K in Illegal Dark Money to Fight Whitmer’s COVID Measures
• PhRMA Gave $16M to Block Drug Price Negotiations in 2022
• PhRMA Donates $300K to RAGA Despite Ongoing Legal Challenges
• PhRMA Gave $530K to Conservative Groups Tied to Leonard Leo and Project 2025 in 2022
• PhRMA’s Latest 2022 IRS Filing Shows Over $1.2 Million In Payments To Opponents of Medicare Drug Price Negotiations
• REPORT: Profits & Investor Handouts Soar Among Top 5 Pharma Companies Amid Industry Price Hikes
• Drug Company Insider Stock Dumping Surged as Taxpayer-Funded Vaccines Moved Toward Approval